Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 1,962 | reported | 02 Jan 2026 | tx 256+499,493−599,660 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 30 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 9,212 | 520.01 USD | |
| 30 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 6,188 | 774.03 USD | |
| 30 Dec 2025 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 9,212 | 0.00 USD | deriv |
| 31 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,948 | 708.19 USD | |
| 31 Dec 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,338 | 413.33 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,958 | 0.00 USD | deriv |
| 31 Dec 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,338 | 0.00 USD | deriv |
| 04 Sept 2024 | GIFT | REGENERON PHARMACEUTICALS, INC. | 1,200 | 0.00 USD | |
| 03 May 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 877 | 942.53 USD | |
| 03 May 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,000 | 413.33 USD | |
| 03 May 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 2,000 | 0.00 USD | deriv |
| 26 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 995.00 USD | |
| 26 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 990.00 USD | |
| 26 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 413.33 USD | |
| 26 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 500 | 413.33 USD | |
| 26 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 0.00 USD | deriv |
| 22 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 970.00 USD | |
| 22 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 413.33 USD | |
| 23 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 500 | 985.00 USD | |
| 22 Feb 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 413.33 USD | |
| 22 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 960.00 USD | |
| 22 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,000 | 965.00 USD |